Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Patients with gelatinous drop-like corneal dystrophy need to be effectively managed as the disease is severely debilitating in view of associated pho-tophobia and glare. Here, we report a rare case of gelatinous drop-like corneal dystrophy effectively managed by intraoperative anterior segment optical coherence tomography-guided manual deep anterior lamellar keratoplasty in 1 eye and sutureless fibrin glue-aided, microkeratome-assisted automated lamellar therapeutic keratoplasty in the other eye. The patient, a 22-year old man, presented with gradual diminution of vision associated with foreign body sensation, glare, photophobia, and watering due to corneal lesions, which were consistent with a diagnosis of gelatinous drop-like corneal dystrophy. Visual acuity at pre-sentation was 4/60 and 3/60 in the right and left eye, respectively. The patient received customized component lamellar keratoplasty in both eyes, and host tissue was sent for histopathologic examination. Treatment resulted in a best-corrected distance visual acuity of 6/9 and 6/12 in the right and left eye, respectively. The graft was clear and well apposed, with minimal interface haze bilaterally. The histopathologic report suggested intralamellar amyloid deposition in the form of homogenous, acellular eosinophilic deposits in the epithelium and anterior corneal stroma. This is a first report of the exclusive use of a fibrin-aprotinin tissue adhesive to stabilize a donor corneal lamellar graft as a treatment modality for a patient with gelatinous drop-like corneal dystrophy, suggesting that this treatment could supplant the need for sutures.

Download full-text PDF

Source
http://dx.doi.org/10.6002/ect.2019.0043DOI Listing

Publication Analysis

Top Keywords

gelatinous drop-like
20
drop-like corneal
20
corneal dystrophy
20
corneal
9
patient gelatinous
8
dystrophy effectively
8
effectively managed
8
lamellar keratoplasty
8
keratoplasty eye
8
eye patient
8

Similar Publications

Purpose: To report a case of gelatinous drop-like corneal dystrophy (GDLD) caused by a novel homozygous tumor-associated calcium signal transducer 2 ( TACSTD2 ) gene mutation and summarize the correlations of clinical phenotypes and genotypes in patients with GDLD.

Methods: We analyzed the clinical characteristics and treatment outcomes of a 42-year-old man with GDLD. The patient with GDLD received multiple keratoplasties, and histopathological staining of the corneal sections was performed.

View Article and Find Full Text PDF

TACSTD2 in gelatinous drop-like corneal dystrophy: variant functional analysis and expression in the cornea after limbal stem cell transplantation.

Hum Genome Var

July 2024

Department of Anterior Segment Transplant and Optical Reconstructive Surgery, S. Fyodorov Eye Microsurgery Complex Federal State Institution, Moscow, Russian Federation.

Gelatinous drop-like corneal dystrophy (GDLD) is a rare autosomal recessive eye disease. GDLD is characterized by the loss of barrier function in corneal epithelial cells (CECs) and amyloid deposition due to pathogenic variants in the TACSTD2 gene. Limbal stem cell transplantation (LSCT) has been suggested as an effective therapeutic alternative for patients with GDLD.

View Article and Find Full Text PDF
Article Synopsis
  • Misfolded glycoproteins in the endoplasmic reticulum (ER) are retained by the enzyme UGGT, which recognizes and marks them for retention by re-glucosylating their N-linked glycans.
  • In the context of certain congenital mutations in the Trop-2 glycoprotein, which is associated with gelatinous drop-like corneal dystrophy (GDLD), these misfolded versions of Trop-2 are unable to reach the plasma membrane and remain trapped in the ER.
  • The study found that inhibiting UGGT1 in mammalian cells can restore membrane localization of these mutants, suggesting that targeting UGGT1 may offer a new treatment approach for diseases caused by similar misfolded glycoproteins that still
View Article and Find Full Text PDF

A non-mutated fingerprint in cancer genetics.

Front Oncol

June 2023

Unit of Medical Genetics, Department of Biomedical Sciences - Biomedical Sciences (BIOMORF), University of Messina, Messina, Italy.

The advent of high throughput DNA sequencing is providing massive amounts of tumor-associated mutation data. Implicit in these analyses is the assumption that, by acquiring a series of hallmark changes, normal cells evolve along a neoplastic path. However, the lack of correlation between cancer risk and global exposure to mutagenic factors provides arguments against this model.

View Article and Find Full Text PDF